Quick Answer
Edwards Lifesciences Corp reported Long-Term Debt of $598.30 million for fiscal year 2025.
Edwards Lifesciences Corp Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $598.30M | +0.1% |
| 2024 | $597.70M | +0.1% |
| 2023 | $597.00M | +0.1% |
| 2022 | $596.30M | +0.1% |
| 2021 | $595.70M | +0.1% |
| 2020 | $595.00M | +0.1% |
| 2019 | $594.40M | +0.1% |
| 2018 | $593.80M | +35.4% |
| 2017 | $438.40M | -46.7% |
| 2016 | $822.30M | +37.8% |
| 2015 | $596.90M | -0.2% |
| 2014 | $598.10M | +0.8% |
| 2013 | $593.10M | +213.3% |
| 2012 | $189.30M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $598.20M | +0.1% | +0.0% |
| June 30, 2025 | $598.00M | +0.1% | +0.0% |
| March 31, 2025 | $597.80M | +0.1% | +0.0% |
| December 31, 2024 | $597.70M | +0.1% | +0.0% |
| September 30, 2024 | $597.50M | +0.1% | +0.0% |
| June 30, 2024 | $597.30M | +0.1% | +0.0% |
| March 31, 2024 | $597.20M | +0.1% | +0.0% |
| December 31, 2023 | $597.00M | +0.1% | +0.0% |
- Edwards Lifesciences Corp showed an increase of +0.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2012–2025 period, Edwards Lifesciences Corp’s long-term debt has grown by 216.1% (from $189.30 million to $598.30 million).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: